Showing results (761-770 of 1,522) with videos related to

Sort By:
Pageof 153
Molecular Cancer Therapeutics|September 20, 2005
The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non-small cell lung cancer xenograftsNathan T Ihle, Gillian Paine-Murrieta, Margareta I Berggren, et al.
American Heart Journal|October 2, 2004
Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registryJoseph A Franciosa, Barry M Massie, Mary Ann Lukas, et al.
European Heart Journal|March 21, 2013
Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory settingMartin R Cowie, Shantanu Sarkar, Jodi Koehler, et al.
Circulation. Heart Failure|March 22, 2013
Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fractionMichael R Zile, Barbro Kjellstrom, Tom Bennett, et al.
Journal of the American College of Cardiology|May 15, 1998
Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failureS F Shakar, W T Abraham, E M Gilbert, et al.
Cardiovascular Research|March 6, 2003
Differential regulation of p38 mitogen-activated protein kinase mediates gender-dependent catecholamine-induced hypertrophyRajesh Dash, Albrecht G Schmidt, Anand Pathak, et al.
American Heart Journal|June 25, 2004
Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and designGregg C Fonarow, William T Abraham, Nancy M Albert, et al.
American Heart Journal|May 28, 2018
The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study designAmish N Raval, Thomas D Cook, Henricus J Duckers, et al.
Cancer Research|February 24, 1999
Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cellsH Hosoi, M B Dilling, T Shikata, et al.
Circulation. Heart Failure|September 10, 2013
Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failureCecilia Linde, Claude Daubert, William T Abraham, et al.
Pageof 153